Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-month open-label modafinil study in pediatric narcolepsy or obstructive sleep apnea/hypopnea
2004-002505-74Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of modafinil in narcolepsy, obstructive sleep apnea hypopnea syndrome (OSAHS) and Excessive Daytime Sleepiness (EDS), sponsored by Cephalon, Inc. Primary endpoint: Safety and tolerability. Started Nov 2004; status: completed.
02
Drugs
modafinil
03
Conditions
narcolepsyobstructive sleep apnea hypopnea syndrome (OSAHS)Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on 2004-002505-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002505-74.